Compare CDRE & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDRE | AZTA |
|---|---|---|
| Founded | 2012 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2021 | 1995 |
| Metric | CDRE | AZTA |
|---|---|---|
| Price | $42.46 | $37.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $34.50 | ★ $43.20 |
| AVG Volume (30 Days) | 221.6K | ★ 685.2K |
| Earning Date | 11-04-2025 | 02-04-2026 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | ★ 33.82 | N/A |
| EPS | ★ 1.11 | N/A |
| Revenue | ★ $619,068,000.00 | $593,821,000.00 |
| Revenue This Year | $12.51 | $6.13 |
| Revenue Next Year | $8.21 | $5.29 |
| P/E Ratio | $38.28 | ★ N/A |
| Revenue Growth | ★ 19.94 | 3.55 |
| 52 Week Low | $27.07 | $23.91 |
| 52 Week High | $46.64 | $55.64 |
| Indicator | CDRE | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 51.87 | 64.50 |
| Support Level | $40.39 | $32.94 |
| Resistance Level | $44.47 | $37.93 |
| Average True Range (ATR) | 1.14 | 1.04 |
| MACD | 0.08 | 0.22 |
| Stochastic Oscillator | 50.04 | 87.68 |
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.